drugset / Trial / NCT06717152
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
Phase 3
Completed
427 enrolled
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
Senju Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Patients with Dry Eye. Patients will be randomly assigned to receive either SJP-0132 or placebo.
Timeline
- Start
- 2024-12-30
- Primary completion
- 2025-07-28
- Completion
- 2025-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SJP-0132 | Unknown | — | Topical |